Your browser doesn't support javascript.
loading
Delay from treatment start to full effect of immunotherapies for multiple sclerosis.
Roos, Izanne; Leray, Emmanuelle; Frascoli, Federico; Casey, Romain; Brown, J William L; Horakova, Dana; Havrdova, Eva K; Trojano, Maria; Patti, Francesco; Izquierdo, Guillermo; Eichau, Sara; Onofrj, Marco; Lugaresi, Alessandra; Prat, Alexandre; Girard, Marc; Grammond, Pierre; Sola, Patrizia; Ferraro, Diana; Ozakbas, Serkan; Bergamaschi, Roberto; Sá, Maria José; Cartechini, Elisabetta; Boz, Cavit; Granella, Franco; Hupperts, Raymond; Terzi, Murat; Lechner-Scott, Jeannette; Spitaleri, Daniele; Van Pesch, Vincent; Soysal, Aysun; Olascoaga, Javier; Prevost, Julie; Aguera-Morales, Eduardo; Slee, Mark; Csepany, Tunde; Turkoglu, Recai; Sidhom, Youssef; Gouider, Riadh; Van Wijmeersch, Bart; McCombe, Pamela; Macdonell, Richard; Coles, Alasdair; Malpas, Charles B; Butzkueven, Helmut; Vukusic, Sandra; Kalincik, Tomas.
Afiliação
  • Roos I; CORe, Department of Medicine, University of Melbourne, Melbourne, 3050, Australia.
  • Leray E; Melbourne MS Centre, Department of Neurology, Royal Melbourne Hospital, Melbourne, 3050, Australia.
  • Frascoli F; Rennes University, EHESP, REPERES (Pharmaco-epidemiology and Health services research) - EA 7449, Rennes, France.
  • Casey R; Faculty of Science, Engineering and Technology, School of Science, Department of Mathematics, Swinburne University of Technology, Melbourne, 3122, Australia.
  • Brown JWL; University of Lyon, Claude Bernard University Lyon 1, F-69000 Lyon, France.
  • Horakova D; Hospices Civils de Lyon, Service de Neurologie, sclérose en plaques, pathologies de la myéline et neuro-inflammation, F-69677 Bron, France.
  • Havrdova EK; Observatoire Français de la Sclérose en Plaques, Lyon Neuroscience Research Centre, INSERM 1028 et CNRS UMR 5292, F-69003 Lyon, France.
  • Trojano M; EUGENE DEVIC EDMUS Foundation against multiple sclerosis, state-approved foundation, F-69677 Bron, France.
  • Patti F; Department of Clinical Neurosciences, University of Cambridge, Cambridge, CB2 0QQ, UK.
  • Izquierdo G; Department of Neurology and Center of Clinical Neuroscience, First Faculty of Medicine, Charles University in Prague and General University Hospital, Prague, 12808, Czech Republic.
  • Eichau S; Department of Neurology and Center of Clinical Neuroscience, First Faculty of Medicine, Charles University in Prague and General University Hospital, Prague, 12808, Czech Republic.
  • Onofrj M; Department of Basic Medical Sciences, Neuroscience and Sense Organs, University of Bari, Bari, 70122, Italy.
  • Lugaresi A; GF Ingrassia Department, University of Catania, Catania, 95123, Italy.
  • Prat A; Policlinico G Rodolico, 95123, Catania, Italy.
  • Girard M; Hospital Universitario Virgen Macarena, Sevilla, 41009, Spain.
  • Grammond P; Hospital Universitario Virgen Macarena, Sevilla, 41009, Spain.
  • Sola P; Department of Neuroscience, Imaging, and Clinical Sciences, University G. d'Annunzio, 66100 Chieti, Italy.
  • Ferraro D; IRCCS Istituto delle Scienze Neurologiche di Bologna, UOSI Riabilitazione Sclerosi Multipla, Bologna, 40139, Italy.
  • Ozakbas S; Department of Biomedical and Neuromotor Sciences, University of Bologna, Bologna, Italy.
  • Bergamaschi R; CHUM MS Center and Universite de Montreal, Montreal, H2L 4M1, Canada.
  • Sá MJ; CHUM MS Center and Universite de Montreal, Montreal, H2L 4M1, Canada.
  • Cartechini E; CISSS Chaudière-Appalache, Lévis, Levis, G6X 0A1, Canada.
  • Boz C; Department of Neuroscience, Azienda Ospedaliera Universitaria, Modena, 41100, Italy.
  • Granella F; Department of Neuroscience, Azienda Ospedaliera Universitaria, Modena, 41100, Italy.
  • Hupperts R; Dokuz Eylul University, Konak/Izmir, 35220, Turkey.
  • Terzi M; IRCCS Mondino Foundation, Pavia, 27100, Italy.
  • Lechner-Scott J; Centro Hospitalar Universitário de São João and Universidade Fernando Pessoa, 4249-004 Porto, Portugal.
  • Spitaleri D; UOC Neurologia, Azienda Sanitaria Unica Regionale Marche - AV3, Macerata, 62100, Italy.
  • Van Pesch V; KTU Medical Faculty Farabi Hospital, Karadeniz Technical University, Trabzon, 61080, Turkey.
  • Soysal A; Department of Medicine and Surgery, University of Parma, Parma, 43126, Italy.
  • Olascoaga J; Department of General Medicine, Parma University Hospital, Parma, 43126, Italy.
  • Prevost J; Zuyderland Ziekenhuis, Sittard, Sittard, 6131 BK, The Netherlands.
  • Aguera-Morales E; Medical Faculty, 19 Mayis University, Kurupelit, Samsun, 55160, Turkey.
  • Slee M; School of Medicine and Public Health, University Newcastle, 2308, Australia.
  • Csepany T; Department of Neurology, John Hunter Hospital, Hunter New England Health, Newcastle, 2305, Australia.
  • Turkoglu R; Azienda Ospedaliera di Rilievo Nazionale San Giuseppe Moscati Avellino, Contrada Amoretta, Avellino, 83100, Italy.
  • Sidhom Y; Cliniques universitaires Saint-Luc, Brussels, 1200 BXL, Belgium.
  • Gouider R; Bakirkoy Education and Research Hospital for Psychiatric and Neurological Diseases, Istanbul, 34142, Turkey.
  • Van Wijmeersch B; Instituto de Investigación Sanitaria Biodonostia, Hospital Universitario Donostia, San San Sebastián, Spain, 20014, Spain.
  • McCombe P; CSSS Saint-Jérôme, Saint-Jérôme, QC J7Z 0H6, Canada.
  • Macdonell R; Hospital Universitario Reina Sofia Cordoba (IMIBIC), 14004 Cordoba, Spain.
  • Coles A; Flinders University, Adelaide, 5042, Australia.
  • Malpas CB; Department of Neurology, Faculty of Medicine, University of Debrecen, Debrecen, 4032, Hungary.
  • Butzkueven H; Haydarpasa Numune Training and Research Hospital, Selimiye Mahallesi, Istanbul, 34668, Turkey.
  • Vukusic S; Department of Neurology, Razi Hospital, 2010, Tunis, Manouba, Tunisia.
  • Kalincik T; Department of Neurology, Razi Hospital, 2010, Tunis, Manouba, Tunisia.
Brain ; 143(9): 2742-2756, 2020 09 01.
Article em En | MEDLINE | ID: mdl-32947619

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Progressão da Doença / Fatores Imunológicos / Imunossupressores / Esclerose Múltipla Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Progressão da Doença / Fatores Imunológicos / Imunossupressores / Esclerose Múltipla Idioma: En Ano de publicação: 2020 Tipo de documento: Article